Allergy to Gum Mastic, Storax, and MSal Alcohol in Relation to NSAIDs
There is no direct cross-reactivity between gum mastic, storax, or MSal alcohol allergies and NSAIDs as a class, but caution is warranted with methyl salicylate-containing NSAIDs like aspirin due to potential chemical similarities. 1
Understanding the Components and Their Relationships
Gum Mastic and Storax
- Gum mastic (from Pistacia lentiscus) and gum storax (from Liquidambar styraciflua) are natural resins used in adhesives like Mastisol 2
- These substances are primarily associated with contact dermatitis rather than systemic allergic reactions 2
- Among patients with Mastisol allergy, 72% react to gum mastic and 44% react to gum storax 2
Methyl Salicylate (MSal) Connection
- Methyl salicylate is a component in Mastisol alongside gum mastic and storax 2
- Methyl salicylate is chemically related to salicylates, including acetylsalicylic acid (aspirin) 3
- This creates a potential concern for cross-reactivity specifically with aspirin and other salicylate NSAIDs
NSAID Hypersensitivity Classification
NSAIDs hypersensitivity reactions fall into two main categories:
Cross-reactive (non-immunologic) reactions:
- Inhibition of COX-1 enzyme leads to altered arachidonic acid metabolism
- Patients react to multiple NSAIDs from different chemical classes
- More common pattern of NSAID hypersensitivity 1
Single NSAID-induced (immunologic) reactions:
- Specific to one NSAID or one chemical class
- Drug-specific immune mechanism
- Less common than cross-reactive patterns 3
Risk Assessment for Patients with Gum Mastic/Storax/MSal Allergies
Higher Risk NSAIDs
- Salicylates (aspirin, diflunisal, salsalate): Highest risk due to chemical similarity to methyl salicylate 3
- These belong to the same chemical class and may trigger reactions in patients with methyl salicylate allergy
Lower Risk NSAIDs
- Propionic acids (ibuprofen, naproxen, ketoprofen)
- Acetic acids (diclofenac)
- Enolic acids (meloxicam)
- COX-2 selective inhibitors (celecoxib)
- These belong to different chemical classes and are less likely to cross-react with methyl salicylate allergy 3, 1
Management Algorithm
Determine the nature of the original reaction:
- Contact dermatitis to Mastisol/adhesives (most common with gum mastic/storax)
- Systemic reaction to methyl salicylate-containing products
For patients with contact dermatitis to gum mastic/storax only:
- Oral NSAIDs are likely safe as the reaction is limited to topical exposure
- Avoid topical NSAIDs that contain methyl salicylate
For patients with systemic reactions to methyl salicylate:
- Avoid salicylate-class NSAIDs (aspirin, diflunisal, salsalate)
- Consider alternative NSAID classes:
- Propionic acids (ibuprofen, naproxen)
- Acetic acids (diclofenac)
- COX-2 selective inhibitors (celecoxib) - safest option 1
If NSAID therapy is essential:
- Consider graded challenge with a non-salicylate NSAID under medical supervision
- Start with COX-2 selective inhibitors which have the lowest risk of cross-reactivity 3
Special Considerations
- Patients with multiple drug allergies or history of severe reactions (anaphylaxis, Stevens-Johnson Syndrome) should be evaluated by an allergist before trying any NSAID 1
- Acetaminophen (paracetamol) is generally well-tolerated in patients with NSAID hypersensitivity and can be considered as an alternative analgesic 4
- Drug provocation tests should only be performed in settings equipped to manage severe hypersensitivity reactions including anaphylaxis 5
Common Pitfalls to Avoid
- Don't assume all NSAIDs will cross-react: Chemical structure matters more than drug class in predicting cross-reactivity
- Don't overlook hidden sources of methyl salicylate: Found in many topical products, mouthwashes, and flavoring agents
- Don't confuse contact allergy with systemic allergy: Contact dermatitis to gum mastic/storax doesn't necessarily predict systemic reactions to oral NSAIDs
- Don't underestimate the severity of potential reactions: Even if the original reaction was mild, subsequent exposures could trigger more severe responses 5